Aditx Therapeutics, Inc. (ADiTxT) is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. ADiTxT’s immune reprogramming technology called Apoptotic DNA Immunotherapy™ (ADi™) is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. The Company’s immune monitoring technology called Aditxt Immune Monitor™ (AiM™) is designed to provide a personalized comprehensive profile of the immune system.

News Feed